Thursday | 4 December, 2008
Biotech briefs
Molloy joins Viralytics
Former Biota CEO Peter Molloy has been appointed a non-executive director of Sydney biotech Viralytics (ASX: VLA).
Viralytics is in Phase 1 trials of an oncolytic virus technology called Cavatak in late-stage metastatic melanoma patients and another in prostate cancer.
Molloy is now a US-based industry consultant.
More About: Viralytics
Additional Resources
Newsletter Subscription
Australian Life Scientist Member Login
IDC Says Asia/Pacific Excluding Japan IT Market Will Remain The Bright Spot... 2008-12-04 15:04:00+11
AOC Launches 18.5” Widescreen Green 16:9 LCD Monitor in Australia and New Zealand 2008-12-03 15:30:00+11
“Just Graphics” isn’t enough any more 2008-11-28 15:02:00+11
Capture and Digitize Your Treasure Moments ~ Compro VideoMate C200 USB A/V Capture Stick 2008-11-26 12:37:00+11
AOC's Widescreen 22" LCD Monitor with All-Aluminum Chassis: Zifas 2218Ph - Flexible flair for discerning users 2008-11-24 13:30:00+11
Sponsored Links
Subscribe to Australian Life Scientist
Australian Life Scientist is Australia's leading magazine for the life sciences sector.
